New Topic Post Reply Printable Version
[ << Previous Thread | Next Thread >> ]

Veteran Member

Date Joined Oct 2006
Total Posts : 626
   Posted 6/8/2007 11:34 AM (GMT -6)   
Just finished reading this months AARP Bulletin.  There is a short article in it reporting John Hopkins has developed a new blood test for prostate cancer.  The new test reduces the amount of false positive biopsies.  According to the article biospies done due to the PSA blood test average 80% false positives.  The new blood test, EPSA-2, in testing had a 3% false positive rate.  EPSA-2 stands for Early Prostate Specitic Antigen - 2.  I wonder if that new test has been standardized in the medical community.  Those on this forum should pass this along to those that post here prior to having a biopsy.
Diagnosed 7/6/06, 1 of 10 core samples, 40%,Stage T1c, Gleason 3+3
Da Vinci on 11/01/06, Catheter out on 11/13/06
56 Years Old
Post Op Path, Gleason 3+3, Approx. 5% of prostate involved
Prostate Confined, margins clear
Undetectable PSA on 12/18/06
No more pads as of 1/13/07
Began injections in April '07

Veteran Member

Date Joined Apr 2006
Total Posts : 818
   Posted 6/9/2007 11:47 PM (GMT -6)   
Thanks for the heads-up, I should have caught that article too, but there is so much stuff I have to read now I haven't even touched the AARP Bulletin.

Diagnosed at age 60
PSA went from 2.2 to 3.8 in 14 months
2 of 14 cores positive at 10%
Gleason 6(3+3), negative DRE, neg. boundaries
DaVinci surgery on 02/23/06

New Topic Post Reply Printable Version
Forum Information
Currently it is Friday, May 25, 2018 4:43 PM (GMT -6)
There are a total of 2,965,936 posts in 325,289 threads.
View Active Threads

Who's Online
This forum has 162690 registered members. Please welcome our newest member, hunterthebunter.
435 Guest(s), 7 Registered Member(s) are currently online.  Details
RedLabel, Ak123, zac26, mpost, MarkInNova, jabele, KarloVen